Published in Am J Health Syst Pharm on May 15, 1999
Structural basis of IAP recognition by Smac/DIABLO. Nature (2001) 3.66
Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature (2000) 3.54
Undergraduate research. Genomics Education Partnership. Science (2008) 3.45
Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci (1997) 2.88
Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med (2001) 2.67
Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc Natl Acad Sci U S A (2000) 2.19
Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci U S A (1997) 2.05
Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia. EMBO J (2000) 1.87
Interaction of Escherichia coli MutS and MutL at a DNA mismatch. J Biol Chem (2001) 1.77
Adult Apaf-1-deficient mice exhibit male infertility. Dev Biol (2000) 1.70
Enteric inhibitory neural regulation of human colonic circular muscle: role of nitric oxide. Gastroenterology (1993) 1.54
DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis. Immunity (2000) 1.52
The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis. Mol Cell Biol (2001) 1.40
The Phe-X-Glu DNA binding motif of MutS. The role of hydrogen bonding in mismatch recognition. J Biol Chem (2001) 1.37
Cocaine-induced cortical microischemia in the rodent brain: clinical implications. Mol Psychiatry (2011) 1.31
Bacillus thuringiensis HD-73 Spores Have Surface-Localized Cry1Ac Toxin: Physiological and Pathogenic Consequences. Appl Environ Microbiol (1996) 1.27
MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene (2011) 1.22
Nitric oxide: mediator of nonadrenergic noncholinergic responses of opossum esophageal muscle. Am J Physiol (1991) 1.20
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. J Clin Oncol (1994) 1.18
A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells. Gene Ther (1997) 1.16
Complete development of Cryptosporidium parvum in bovine fallopian tube epithelial cells. Infect Immun (1996) 1.16
Activity and autophosphorylation of LAMMER protein kinases. J Biol Chem (1996) 1.15
Occupational exposure to benzene in China. Br J Ind Med (1987) 1.14
Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis. J Neuroimmunol (1998) 1.12
Conservation of cys-cys trp structural triads and their geometry in the protein domains of immunoglobulin superfamily members. Mol Immunol (1999) 1.10
Taxol: a history of pharmaceutical development and current pharmaceutical concerns. J Natl Cancer Inst Monogr (1993) 1.07
Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet (1991) 1.07
Genomic organization of the human retinoblastoma gene. Oncogene (1989) 1.04
A technique for studying chemotaxis of leucocytes in well-defined chemotactic fields. Exp Cell Res (1973) 1.04
Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. Cytotherapy (2004) 1.03
Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma. Leukemia (2010) 1.01
Enamel proteases reduce amelogenin-apatite binding. J Dent Res (2008) 1.01
Ischemic dysfunction in transgenic mice expressing troponin I lacking protein kinase C phosphorylation sites. Am J Physiol Heart Circ Physiol (2001) 1.01
Pilot trial of 1-octanol in essential tremor. Neurology (2004) 1.00
Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis. J Immunol (1999) 0.98
Non-invasive image acquisition and advanced processing in optical bioimaging. Comput Med Imaging Graph (1998) 0.96
Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline. J Immunol (1998) 0.96
Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny. Blood (1998) 0.94
Development of a questionnaire for detecting potential adverse drug reactions. Ann Pharmacother (1992) 0.93
Infection of immunosuppressed C57BL/6N adult mice with a single oocyst of Cryptosporidium parvum. J Parasitol (2000) 0.93
Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis. J Appl Physiol (1985) (1999) 0.93
Infectivity of preserved Cryptosporidium parvum oocysts for immunosuppressed adult mice. FEMS Immunol Med Microbiol (1996) 0.92
Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum. J Parasitol (1995) 0.92
Standardizing the expression and nomenclature of cancer treatment regimens. American Society of Health-System Pharmacist (ASHP), American Medical Association (AMA), American Nurses Association (ANA). Am J Health Syst Pharm (1998) 0.92
Heat shock protein 27 mediates repression of androgen receptor function by protein kinase D1 in prostate cancer cells. Oncogene (2009) 0.91
Stability of sodium ampicillin in aqueous solutions. Am J Hosp Pharm (1972) 0.91
Cycloheximide reduces infarct volume when administered up to 6 h after mild focal ischemia in rats. Brain Res (2001) 0.91
Decreased renal ischemia-reperfusion injury by IL-16 inactivation. Kidney Int (2007) 0.90
Paclitaxel (taxol). Pharmacotherapy (1994) 0.88
Quantitation of flupirtine and its active acetylated metabolite by reversed-phase high-performance liquid chromatography using fluorometric detection. J Chromatogr (1984) 0.88
Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells. J Biomech (2005) 0.88
Prospective cost analysis of moxalactam versus clindamycin plus gentamicin for endomyometritis after cesarean section. Antimicrob Agents Chemother (1988) 0.87
Guanylate cyclase inhibitors: effect on tone, relaxation, and cGMP content of lower esophageal sphincter. Am J Physiol (1992) 0.86
Guanylate cyclase inhibitors: effect on inhibitory junction potentials in esophageal smooth muscle. Am J Physiol (1992) 0.86
Efficacy of serine protease inhibitors against Cryptosporidium parvum infection in a bovine fallopian tube epithelial cell culture system. J Parasitol (1996) 0.86
Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma. J Natl Cancer Inst (1993) 0.85
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas. J Clin Oncol (1995) 0.85
Stability of solutions of essential amino acids. Am J Hosp Pharm (1973) 0.84
Systemic bioavailability and pharmacokinetics of methylprednisolone in patients with rheumatoid arthritis following 'high-dose' pulse administration. Biopharm Drug Dispos (1983) 0.83
Modulation of nicotinic AChR channels by prostaglandin E2 in chick sympathetic ganglion neurons. J Neurophysiol (1998) 0.82
Contingent negative variation and movement-related cortical potentials in parkinsonism. Electroencephalogr Clin Neurophysiol (1995) 0.82
Recommendations for the safe handling of injectable antineoplastic drug products. Am J Hosp Pharm (1981) 0.82
In vivo modulation of intestinal motility and sites of opioid effects in the rat. Regul Pept (1984) 0.81
Characterization and mediation of inhibitory junction potentials from opossum lower esophageal sphincter. Gastroenterology (1993) 0.81
Mimosine differentially inhibits DNA replication and cell cycle progression in somatic cells compared to embryonic cells of Xenopus laevis. Exp Cell Res (1995) 0.81
Lack of mutagenic activity in urine from hospital pharmacists admixing antitumour drugs. Lancet (1981) 0.81
Stability of cisplatin in aqueous solution. Am J Hosp Pharm (1979) 0.81
Pathways of slow-wave propagation in proximal colon of cats. Am J Physiol (1990) 0.80
Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment. Thorax (1993) 0.80
Disposal of antineoplastic wastes at the National Institutes of Health. Am J Hosp Pharm (1984) 0.79
[Studies on glucose-6-phosphate dehydrogenase (G6PD) deficiency in China: forty years retrospection and perspective]. Zhonghua Xue Ye Xue Za Zhi (2000) 0.79
Rhod-2 based measurements of intracellular calcium in the perfused mouse heart: cellular and subcellular localization and response to positive inotropy. J Biomed Opt (2001) 0.79
Phase I study of paclitaxel in combination with cyclophosphamide and granulocyte colony-stimulating factor in metastatic breast cancer patients. J Clin Oncol (1996) 0.79
Absorption of micronized progesterone from a nonliquefying vaginal cream. Fertil Steril (1991) 0.79
Ondansetron: a serotonin receptor (5-HT3) antagonist for antineoplastic chemotherapy-induced nausea and vomiting. DICP (1991) 0.79
Adaptive control with feedback strategies for suramin dosing. Clin Pharmacol Ther (1992) 0.79
A pilot study of amiodarone with infusional doxorubicin or vinblastine in refractory breast cancer. Cancer Chemother Pharmacol (1995) 0.78
[Detection of R277Q mutation of SRD5alpha2 gene by amplification refractory mutation system]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (1999) 0.78
A novel mis-sense mutation (G1381A) in the G6PD gene identified in a Chinese man. Chin Med J (Engl) (2001) 0.78
[SEM study of machinable vita cerec mark II porcelain surface morphology after HF acid etching]. Hua Xi Kou Qiang Yi Xue Za Zhi (1998) 0.77
Kinetics of chlorambucil hydrolysis using high-pressure liquid chromatography. J Pharm Sci (1982) 0.77
Thermal and photolytic decomposition of methotrexate in aqueous solutions. J Pharm Sci (1978) 0.77
Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes. Antiviral Res (1986) 0.77
Patient-interactive computer system for obtaining medication histories. Am J Hosp Pharm (1993) 0.77
Compensatory changes in Ca(2+) and myocardial O(2) consumption in beta-tropomyosin transgenic hearts. Am J Physiol Heart Circ Physiol (2001) 0.76
Chemical destruction and disposal of antineoplastic drugs. Am J Hosp Pharm (1986) 0.76
Issues in antiemetic therapy. Cancer (1996) 0.75
High calcium and dobutamine positive inotropy in the perfused mouse heart: myofilament calcium responsiveness, energetic economy, and effects of protein kinase C inhibition. BMC Physiol (2001) 0.75
Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy. Obstet Gynecol (1994) 0.75
Visual compatibility of zidovudine with other injectable drugs during simulated Y-site administration. Am J Hosp Pharm (1988) 0.75
Bovine fallopian tube epithelial cells, adult C57BL/6 mice, and non-neonatal pigs as models for cryptosporidiosis. J Eukaryot Microbiol (1998) 0.75
[Factors analysis on ceramic crack of metal-ceramic restorations]. Hua Xi Kou Qiang Yi Xue Za Zhi (1998) 0.75
[p16INK4/CDKN2 gene deletions and mutations in non-small cell lung cancers]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (1998) 0.75
[Construction of a competitor for bcr-abl cDNA by recombinant PCR]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (1998) 0.75
[Shear bond test of HF acid etching machinable porcelain bonded to enamel with different concentration and disposing time]. Hua Xi Kou Qiang Yi Xue Za Zhi (1998) 0.75
AIDS facts for pharmacists. Am J Hosp Pharm (1988) 0.75
[The correlation between lung cancer lymph node metastasis and nm23-H1 gene mutation, mRNA expression]. Zhonghua Jie He He Hu Xi Za Zhi (1997) 0.75
Stability of zidovudine in 5% dextrose injection and 0.9% sodium chloride injection. Am J Hosp Pharm (1991) 0.75
[Identification of G6PD gene mutations in several nationalities from Yunnan province]. Zhonghua Xue Ye Xue Za Zhi (1997) 0.75
Stability of concentrated trimethoprim-sulfamethoxazole admixtures. Am J Hosp Pharm (1989) 0.75